Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease.
about
Treatment of Cushing disease: overview and recent findings2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.Endocrine clinical update: where are we in the therapeutic management of pituitary-dependent hypercortisolism?Cushing's syndrome: aftermath of the cure.Skeletal involvement in adult patients with endogenous hypercortisolism.A case of cushing syndrome diagnosed by recurrent pathologic fractures in a young woman.Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing's syndrome.Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease.Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study.Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease.Fracture risk assessment before and after resolution of endogenous hypercortisolism: is the FRAX® algorithm useful?Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender.Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
P2860
Q24626819-10596D19-C189-4C04-9620-F8B29081778FQ34300668-50D260FE-3BBE-4993-9A70-5B3A6E085D55Q36940053-8F3EB313-7B52-4745-88AE-BD06BDFD58C4Q37062081-D254E93C-841C-40DE-8F24-433C8ACDA8C0Q37133892-A628A3C2-6C5D-46A0-951B-7EAAF29C33C9Q37192077-F31B753E-9665-45ED-915E-FB8882995C26Q38015162-5C429F3B-8B08-48A0-8DC7-7BD8E75EE006Q43268923-66DAC99B-F0BB-443B-BB93-799A82BC96C2Q43902744-1DE1530A-A1B1-4809-AB7A-B3BE1ADB6555Q44331759-E66C72D3-098D-4F93-8790-3E0CCFF4FF09Q46542918-F5375510-330E-42BC-A15E-97D5543B4EBCQ46561872-47D6BE39-B75B-4ABD-980A-90D0E35805DFQ46685774-C63E7366-048D-4492-A3D8-034879A3E0FBQ48908924-2356C5B2-320A-419B-B576-3181841490D3
P2860
Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Effectiveness of chronic treat ...... oporosis of Cushing's disease.
@en
Effectiveness of chronic treat ...... oporosis of Cushing's disease.
@nl
type
label
Effectiveness of chronic treat ...... oporosis of Cushing's disease.
@en
Effectiveness of chronic treat ...... oporosis of Cushing's disease.
@nl
prefLabel
Effectiveness of chronic treat ...... oporosis of Cushing's disease.
@en
Effectiveness of chronic treat ...... oporosis of Cushing's disease.
@nl
P2093
P2860
P50
P1476
Effectiveness of chronic treat ...... oporosis of Cushing's disease.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2265.1998.00486.X
P577
1998-05-01T00:00:00Z